Positive Development Expands Autism Therapy Model with $51.5M Funding

Deal News | Aug 06, 2025 | Digitalis Ventures LLC

Positive Development Expands Autism Therapy Model with $51.5M Funding

Positive Development, a leader in developmental therapy for autistic children, has successfully raised $51.5 million in a Series C funding round. New investor aMoon co-led the funding alongside existing backers B Capital and Flare Capital Partners, with continued investments from Digitalis Ventures and others. This funding will be utilized to expand Positive Development's Developmental Relationship-Based Interventions (DRBI) model, which integrates speech, occupational, and mental health therapies. The model offers a lower-cost alternative to traditional Applied Behavioral Analysis (ABA) therapies, aligning with healthcare systems' desires for affordable and effective autism care. Positive Development's approach not only delivers measurable outcomes with fewer hours but also maintains extensive partnerships with payers and Medicaid programs, setting a new standard in autism care.

Sectors

  • Healthcare Services
  • Private Equity & Venture Capital

Geography

  • United States – Positive Development operates within the United States, and much of the narrative around healthcare service enhancement is focused on this region.

Industry

  • Healthcare Services – The article discusses Positive Development and its services geared towards providing autism care through developmental therapy, aligning this with the healthcare services industry.
  • Private Equity & Venture Capital – The involvement of investors such as Digitalis Ventures, B Capital, and aMoon in funding Positive Development positions the article within this sector.

Financials

  • $51.5M – The amount raised by Positive Development in its Series C funding round.
  • $50,000 to $70,000 – The yearly cost range for traditional, intensive Applied Behavioral Analysis (ABA) interventions for autistic children.
  • 50% – The cost percentage savings offered by Positive Development's care model compared to a traditional ABA program.

Participants

NameRoleTypeDescription
Positive DevelopmentTarget CompanyCompanyA leading developmental therapy provider for autistic children and their families.
Digitalis Ventures LLCInvestorCompanyA venture capital firm participating in the Series C funding round for Positive Development.
aMoonInvestorCompanyNew investor co-leading the Series C round for Positive Development.
B CapitalInvestorCompanyAn existing investor co-leading the Series C funding round for Positive Development.
Flare Capital PartnersInvestorCompanyA participant in Positive Development’s Series C funding round.
Healthworx (CareFirst Inc.)InvestorCompanyThe innovation and investment arm of CareFirst Inc., investing in Positive Development.
Mike SuitersCo-founder & CEOPersonCEO of Positive Development, overseeing the company's strategic growth and therapy model expansion.
Dr. Tomer BerkovitzManaging Partner at aMoon and Board MemberPersonManaging Partner at aMoon who joined Positive Development’s Board of Directors as part of the Series C round.
Adam SeabrookPartner at B CapitalPersonA partner at B Capital who commented on Positive Development’s unique therapy model and funding round.